1
Clinical Trials associated with AVT-80A Randomised, Parallel Group Treatment, Double-blind, 3-arm Study to Investigate the Comparative Pharmacokinetics, Safety, Immunogenicity, and Tolerability Between AVT80 and Entyvio® in Healthy Male and Female Participants Aged 18 to 55 Years Inclusive
The study has been designed as a randomised, parallel-group, double-blind, 3 arm study to investigate the comparative pharmacokinetics, safety, immunogenicity and tolerability between AVT80 and Entyvio in healthy volunteers.
100 Clinical Results associated with AVT-80
100 Translational Medicine associated with AVT-80
100 Patents (Medical) associated with AVT-80
100 Deals associated with AVT-80